Related Experiment Video
Updated: Jun 29, 2025
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
Individualized Pharmacotherapy Utilizing Genetic Biomarkers and Novel In Vitro Systems As Predictive Tools for
Magnus Ingelman-Sundberg1, Volker M Lauschke2
1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (M.I.-S., V.M.L.); Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany (V.M.L.); and University of Tübingen, Tübingen, Germany (V.M.L.) magnus.ingelman-sundberg@ki.se.
Summary
Pharmacogenomics and advanced in vitro systems are rapidly evolving to predict drug pharmacokinetics and adverse drug reactions (ADRs). This update reviews their current status and future potential for personalized pharmacotherapy.
Area of Science:
- Pharmacology
- Genetics
- Drug Development
Background:
- Understanding drug absorption, distribution, metabolism, and excretion (ADME) variations is crucial for safe and effective pharmacotherapy.
- Interindividual genetic differences significantly impact drug response and the risk of adverse drug reactions (ADRs).
- In vitro systems offer predictive models for drug metabolism and toxicity.
Purpose of the Study:
- To provide an updated overview of the current status of pharmacogenomics and in vitro systems.
- To highlight advancements in predicting drug pharmacokinetics and ADRs.
- To explore future directions for personalized pharmacotherapy.
Main Methods:
- Review of current literature on pharmacogenomics.
- Assessment of advancements in in vitro predictive models.
- Analysis of their application in drug development and clinical pharmacotherapy.
Main Results:
- Pharmacogenomics and in vitro systems are rapidly expanding fields.
- These technologies show significant promise in predicting individual drug responses.
- Improved understanding of ADME genetics enhances ADR risk assessment.
Conclusions:
- Pharmacogenomics and in vitro systems are essential tools for personalized medicine.
- Continued development will lead to more precise and safer drug therapies.
- These advancements aim to optimize pharmacotherapy for individual patients.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:26Drug Administration and Therapy Phases: Overview
457
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
457
01:28Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716